Teva Pharmaceutical Industries Ltd Stock Ownership

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
Hafrun FridriksdottirExecutive VP Global R&D2021-08-1050,860$9.95
Eric DrapeExecutive VP Global Operations2021-05-2140,000$11.01
Eric DrapeExecutive VP Global Operations2021-05-1119,804$10.22
David Matthew StarkExec. VP Chief Legal Officer2021-05-1137,884$10.22
Hafrun FridriksdottirExecutive VP Global R&D2021-05-1119,066$10.22
Mark SabagSee "Remarks" below2021-03-16127,244$11.22
Brendan P. 1. OgradyEVP North America Commercial2021-03-0511,436$10.54
Richard DaniellExec. VP European Commercial2021-03-047,513$10.58
Hafrun FridriksdottirExecutive VP Global R&D2021-03-049,515$10.57
David Matthew StarkExec. VP Chief Legal Officer2021-03-0413,930$10.57

1 of 5

TEVA insiders have sold more... subscribe to Premium to read more.

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Capital Research Global Investors10.78%118,876,651$1.01BInstitution
Berkshire Hathaway Inc3.88%42,789,295$364.14MInstitution
Blackrock Inc3.68%40,541,845$345.01MInstitution
Abrams Capital Management LP2.18%24,046,356$204.63MInstitution
Migdal Insurance Financial Holdings Ltd1.93%21,284,555$181.13MInstitution
Menora Mivtachim Holdings Ltd1.77%19,564,520$166.49MInstitution
Clal Insurance Enterprises Holdings Ltd1.60%17,658,566$150.27MInstitution
State Street Corp1.59%17,533,567$149.21MInstitution
Phoenix Holdings Ltd1.28%14,170,801$120.59MInstitution
Susquehanna International Group Llp0.99%10,924,962$92.97MInstitution

1 of 3

Teva Pharmaceutical Industries Ltd Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is owned by 47.75% institutional shareholders, 0.67% Teva Pharmaceutical Industries Ltd insiders, and 51.57% retail investors. Capital Research Global Investors is the largest individual Teva Pharmaceutical Industries Ltd shareholder, owning 118.88M shares representing 10.78% of the company. Capital Research Global Investors's Teva Pharmaceutical Industries Ltd shares are currently valued at $1.01B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.